Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 721 of 1,261
  1. US 9199908

    Compounds and methods for delivery of prostacyclin analogs

    United Therapeutics Corporation · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  2. US 9199975

    Biaryl imidazole derivatives for regulating CYP17

    Asana BioSciences, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  3. US 9198989

    Radioactive bone cement

    The Regents of the University of California · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  4. US 9198983

    Compositions and methods for inhibiting expression of Mylip/Idol gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  5. US 9198976

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  6. US 9198959

    Adenovirus vaccine vector and methods of use

    Regents of the University of Minnesota · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  7. US 9198972

    Monomers and oligonucleotides comprising cycloaddition adduct(s)

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  8. US 9198961

    Bacterial extract for digestive or urinary tract disorders and process for its preparation

    OM PHARMA · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  9. US 9198921

    Non-hormonal steroid modulators of NF-κB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  10. US 9198915

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  11. US 9198926

    Methods and compositions comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  12. US 9198941

    Yeast-Brachyury immunotherapeutic compositions

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  13. US 9198927

    Targeting opposite strand replication intermediates of single-stranded viruses by RNAI

    Alnylam Pharmaceuticals, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  14. US 9198893

    Combination antitumor therapy

    Galera Labs, LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  15. US 9198842

    Multicomponent glasses for use in personal care products

    Repregen Limited · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  16. US 9198901

    Tris(hydroxymethyl)aminomethane salts of a small-molecule GLP1R agonist and pharmaceutical compositions and uses thereof

    VTV THERAPEUTICS LLC · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  17. US 9198882

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  18. US 9198453

    Methods of reducing blood lactate concentration

    Stokely-Van Camp, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  19. US 9192575

    Sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  20. US 9193790

    Use of antagonists of the interaction between HIV GP120 and A4B7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  21. US 9193769

    Bovine adeno-associated viral (BAAV) vector and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  22. US 9194011

    Stabilized alpha-galactosidase and uses thereof

    Protalix Ltd. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  23. US 9193740

    Bismacrocyclic compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted
  24. US 9193977

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 24, 2015 · Expires Nov 19, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.